 SEATTLE, April 15, 2021 GLOBE NEWSWIRE -- Chinook Therapeutics, Inc. NASDAQ: KDNY, a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced six poster presentations at the ISN World Congress of Nephrology 2021 WCN 21. 